Vyome Holdings, Inc. (HIND)
2.19
-0.05
(-2.32%)
USD |
NASDAQ |
Aug 25, 09:30
Vyome Holdings Net Income (Quarterly) : -0.7197M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7197M |
| March 31, 2026 | -0.9855M |
| December 31, 2025 | -1.280M |
| September 30, 2025 | -8.595M |
| June 30, 2025 | -0.3088M |
| March 31, 2025 | -0.294M |
| December 31, 2024 | -0.3066M |
| September 30, 2024 | -0.5478M |
| June 30, 2024 | -1.595M |
| March 31, 2024 | -2.193M |
| December 31, 2023 | -1.698M |
| September 30, 2023 | -3.534M |
| June 30, 2023 | -3.493M |
| March 31, 2023 | -2.662M |
| December 31, 2022 | -16.61M |
| September 30, 2022 | -12.19M |
| June 30, 2022 | -9.444M |
| March 31, 2022 | -8.115M |
| December 31, 2021 | -35.46M |
| September 30, 2021 | -17.70M |
| Date | Value |
|---|---|
| June 30, 2021 | -3.902M |
| March 31, 2021 | -4.874M |
| December 31, 2020 | -8.536M |
| September 30, 2020 | -5.179M |
| June 30, 2020 | -3.604M |
| March 31, 2020 | -5.261M |
| December 31, 2019 | -4.913M |
| September 30, 2019 | -3.706M |
| June 30, 2019 | -6.767M |
| March 31, 2019 | -8.29M |
| December 31, 2018 | -8.756M |
| September 30, 2018 | -6.745M |
| June 30, 2018 | -9.753M |
| March 31, 2018 | -12.13M |
| December 31, 2017 | -10.12M |
| September 30, 2017 | -9.17M |
| June 30, 2017 | -7.73M |
| March 31, 2017 | -7.745M |
| December 31, 2016 | -7.495M |
| September 30, 2016 | -5.26M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -0.1372M |
| Anika Therapeutics, Inc. | 3.309M |
| Enovis Corp. | -1.036M |
| Edwards Lifesciences Corp. | 241.40M |
| Perspective Therapeutics, Inc. | -26.98M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.027M |
| Total Expenses (Quarterly) | 0.7125M |
| EPS Diluted (Quarterly) | -0.0977 |
| Enterprise Value | 9.128M |
| Gross Profit Margin (Quarterly) | 33.33% |
| Profit Margin (Quarterly) | -2.67K% |
| Earnings Yield | -160.1% |
| Normalized Earnings Yield | -70.81 |